These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23829355)

  • 1. Regulation of aldosterone biosynthesis by the Kir3.4 (KCNJ5) potassium channel.
    Velarde-Miranda C; Gomez-Sanchez EP; Gomez-Sanchez CE
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):895-901. PubMed ID: 23829355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KCNJ5 mutations in aldosterone producing adenoma and relationship with adrenal cortex remodeling.
    Boulkroun S; Golib Dzib JF; Samson-Couterie B; Rosa FL; Rickard AJ; Meatchi T; Amar L; Benecke A; Zennaro MC
    Mol Cell Endocrinol; 2013 May; 371(1-2):221-7. PubMed ID: 23376008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.
    Choi M; Scholl UI; Yue P; Björklund P; Zhao B; Nelson-Williams C; Ji W; Cho Y; Patel A; Men CJ; Lolis E; Wisgerhof MV; Geller DS; Mane S; Hellman P; Westin G; Åkerström G; Wang W; Carling T; Lifton RP
    Science; 2011 Feb; 331(6018):768-72. PubMed ID: 21311022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minireview: potassium channels and aldosterone dysregulation: is primary aldosteronism a potassium channelopathy?
    Gomez-Sanchez CE; Oki K
    Endocrinology; 2014 Jan; 155(1):47-55. PubMed ID: 24248457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.
    Oki K; Plonczynski MW; Luis Lam M; Gomez-Sanchez EP; Gomez-Sanchez CE
    Endocrinology; 2012 Apr; 153(4):1774-82. PubMed ID: 22315453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
    Kuppusamy M; Caroccia B; Stindl J; Bandulik S; Lenzini L; Gioco F; Fishman V; Zanotti G; Gomez-Sanchez C; Bader M; Warth R; Rossi GP
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1765-73. PubMed ID: 25057880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potassium channel, Kir3.4 participates in angiotensin II-stimulated aldosterone production by a human adrenocortical cell line.
    Oki K; Plonczynski MW; Lam ML; Gomez-Sanchez EP; Gomez-Sanchez CE
    Endocrinology; 2012 Sep; 153(9):4328-35. PubMed ID: 22798349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrolides Blunt Aldosterone Biosynthesis: A Proof-of-Concept Study in
    Caroccia B; Prisco S; Seccia TM; Piazza M; Maiolino G; Rossi GP
    Hypertension; 2017 Dec; 70(6):1238-1242. PubMed ID: 28993452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance.
    Cheng CJ; Sung CC; Wu ST; Lin YC; Sytwu HK; Huang CL; Lin SH
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E155-63. PubMed ID: 25347571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.
    Scholl UI; Lifton RP
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):141-7. PubMed ID: 23318698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma.
    Zheng FF; Zhu LM; Nie AF; Li XY; Lin JR; Zhang K; Chen J; Zhou WL; Shen ZJ; Zhu YC; Wang JG; Zhu DL; Gao PJ
    Hypertension; 2015 Mar; 65(3):622-8. PubMed ID: 25624344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18-Oxocortisol Synthesis in Aldosterone-Producing Adrenocortical Adenoma and Significance of KCNJ5 Mutation Status.
    Tezuka Y; Yamazaki Y; Kitada M; Morimoto R; Kudo M; Seiji K; Takase K; Kawasaki Y; Mitsuzuka K; Ito A; Nishikawa J; Asai N; Nakamura Y; Gomez-Sanchez CE; Ito S; Dezawa M; Sasano H; Satoh F
    Hypertension; 2019 Jun; 73(6):1283-1290. PubMed ID: 31006333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSTA1 Expression Is Correlated With Aldosterone Level in KCNJ5-Mutated Adrenal Aldosterone-Producing Adenoma.
    Li X; Wang B; Tang L; Zhang Y; Chen L; Gu L; Zhang F; Ouyang J; Zhang X
    J Clin Endocrinol Metab; 2018 Mar; 103(3):813-823. PubMed ID: 29165597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human adrenal glomerulosa cells express K2P and GIRK potassium channels that are inhibited by ANG II and ACTH.
    Enyeart JJ; Enyeart JA
    Am J Physiol Cell Physiol; 2021 Jul; 321(1):C158-C175. PubMed ID: 34038243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas.
    Yamada M; Nakajima Y; Taguchi R; Okamura T; Ishii S; Tomaru T; Ozawa A; Shibusawa N; Yoshino S; Toki A; Ishida E; Hashimoto K; Satoh T; Mori M
    Endocr J; 2012; 59(8):735-41. PubMed ID: 22863749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter.
    Åkerström T; Crona J; Delgado Verdugo A; Starker LF; Cupisti K; Willenberg HS; Knoefel WT; Saeger W; Feller A; Ip J; Soon P; Anlauf M; Alesina PF; Schmid KW; Decaussin M; Levillain P; Wängberg B; Peix JL; Robinson B; Zedenius J; Bäckdahl M; Caramuta S; Iwen KA; Botling J; Stålberg P; Kraimps JL; Dralle H; Hellman P; Sidhu S; Westin G; Lehnert H; Walz MK; Åkerström G; Carling T; Choi M; Lifton RP; Björklund P
    PLoS One; 2012; 7(7):e41926. PubMed ID: 22848660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone Suppression by Dexamethasone in Patients With KCNJ5-Mutated Aldosterone-Producing Adenoma.
    Inoue K; Yamazaki Y; Kitamoto T; Hirose R; Saito J; Omura M; Sasano H; Nishikawa T
    J Clin Endocrinol Metab; 2018 Sep; 103(9):3477-3485. PubMed ID: 30020487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different Somatic Mutations in Multinodular Adrenals With Aldosterone-Producing Adenoma.
    Fernandes-Rosa FL; Giscos-Douriez I; Amar L; Gomez-Sanchez CE; Meatchi T; Boulkroun S; Zennaro MC
    Hypertension; 2015 Nov; 66(5):1014-22. PubMed ID: 26351028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary somatic mutations of KCNJ5, ATP1A1, and ATP2B3 in sporadic aldosterone producing adrenal adenomas.
    Dutta RK; Welander J; Brauckhoff M; Walz M; Alesina P; Arnesen T; Söderkvist P; Gimm O
    Endocr Relat Cancer; 2014 Feb; 21(1):L1-4. PubMed ID: 24179102
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeted disruption of the
    Hardege I; Long L; Al Maskari R; Figg N; O'Shaughnessy KM
    Clin Sci (Lond); 2018 Jan; 132(1):145-156. PubMed ID: 29222092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.